IMRT 2018

Projected RT need for lymphomas

Top 5 ranking by absolute number of cancer patients requiring RT in 2025

Cancer cases with an evidence based Indication for RT in 2012 and 2025 in Europe (most important tumor sites)

Tumor site

2012

2025

Breast

396.891 437.415 (+10.2%)

Lung

315.197 371.755 (+17.9%)

Prostate

243.669 303.162 (+24.4%)

Head&Neck

108.194 121.531 (+12.3%)

Rectum

99.493 117.807 (+18.4%)

Lymphoma

74.852

84.723 (+13.2%)

Borras JM. et al. Radiot & Oncol 2016